Investigational Drug Details
| Drug ID: | D166 |
| Drug Name: | HepaStem |
| Synonyms: | -- |
| Type: | Biological drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | 2166483-24-3 |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | Cell therapy drug |
| Clinical Trial Progress: | Phase 1&2 completed (NCT03963921) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0279 | NCT03963921 | Phase 1/Phase 2 | Completed | No Results Available | April 9, 2019 | October 14, 2020 | Details |
| L0483 | EUCTR2018-004449-18-FR | Phase 2 | Not Recruiting | No Results Available | 27/12/2018 | 23 November 2020 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Article ID | PMID | Source | Title |
|---|